Amphastar Pharmaceuticals (AMPH) Current Leases (2019 - 2026)
Amphastar Pharmaceuticals has reported Current Leases over the past 7 years, most recently at $7.9 million for Q4 2025.
- For Q4 2025, Current Leases rose 16.52% year-over-year to $7.9 million; the TTM value through Dec 2025 reached $7.9 million, up 16.52%, while the annual FY2025 figure was $7.9 million, 16.52% up from the prior year.
- Current Leases for Q4 2025 was $7.9 million at Amphastar Pharmaceuticals, up from $7.8 million in the prior quarter.
- Over five years, Current Leases peaked at $7.9 million in Q4 2025 and troughed at $2.9 million in Q3 2021.
- A 5-year average of $4.5 million and a median of $3.7 million in 2021 define the central range for Current Leases.
- Biggest five-year swings in Current Leases: fell 21.35% in 2021 and later skyrocketed 97.17% in 2025.
- Year by year, Current Leases stood at $3.0 million in 2021, then increased by 0.7% to $3.0 million in 2022, then surged by 30.07% to $3.9 million in 2023, then skyrocketed by 74.19% to $6.8 million in 2024, then increased by 16.52% to $7.9 million in 2025.
- Business Quant data shows Current Leases for AMPH at $7.9 million in Q4 2025, $7.8 million in Q3 2025, and $7.9 million in Q2 2025.